发明名称 Oligonucleotide therapeutic agent and methods of making same
摘要 For use in controlling biologic functions in an organism, a stabilized oligonucleotide, preferably in a phosphotriester form, having a base sequence substantially complementary to a portion of messenger ribonucleic acid coding for a biological component, such as a protein, of the organism. The oligonucleotide has about fourteen bases or more, such as twenty-three bases, and can be a deoxyribo-nucleotide. The oligonucleotide sequence can be derived from the organism's ribonucleic or deoxyribonucleic acid that codes for a vital protein, and can be synthesized in bulk either chemically or by insertion into a plasmid.
申请公布号 US7285537(B1) 申请公布日期 2007.10.23
申请号 US19930078768 申请日期 1993.06.16
申请人 ISIS PHARMACEUTICALS, INC. 发明人 TULLIS RICHARD H.
分类号 A61K31/7088;C12P19/34;A01H1/00;A61K31/70;A61K31/7135;A61K35/00;A61K35/12;A61K35/74;A61K38/00;C07H1/00;C07H21/00;C07H21/02;C07H21/04;C12N5/10;C12N15/00;C12N15/09;C12N15/113;C12P21/00;C12Q1/68;C12R1/92;F02C6/12 主分类号 A61K31/7088
代理机构 代理人
主权项
地址